BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33033873)

  • 1. Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion.
    Farinha S; Moura C; Afonso MD; Henriques J
    AAPS PharmSciTech; 2020 Oct; 21(7):274. PubMed ID: 33033873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.
    Ghalanbor Z; Körber M; Bodmeier R
    Pharm Res; 2010 Feb; 27(2):371-9. PubMed ID: 20033474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
    Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.
    Vesna Milacic VM; Schwendeman SP
    Pharm Res; 2014 Feb; 31(2):436-48. PubMed ID: 23959854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
    Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
    Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
    Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
    Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
    Yoncheva K; Lambov N; Miloshev S
    Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milling solid proteins to enhance activity after melt-encapsulation.
    Lee PW; Maia J; Pokorski JK
    Int J Pharm; 2017 Nov; 533(1):254-265. PubMed ID: 28939464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants.
    Cossé A; König C; Lamprecht A; Wagner KG
    AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of raloxifene hydrochloride-loaded subdermal implants using hot-melt extrusion technology.
    Muhindo D; Ashour EA; Almutairi M; Repka MA
    Int J Pharm; 2022 Jun; 622():121834. PubMed ID: 35597391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
    Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
    J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising poly(lactic-co-glycolic acid) microparticle fabrication using a Taguchi orthogonal array design-of-experiment approach.
    Mensah RA; Kirton SB; Cook MT; Styliari ID; Hutter V; Chau DYS
    PLoS One; 2019; 14(9):e0222858. PubMed ID: 31557205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor.
    Xu J; Zhang S; Machado A; Lecommandoux S; Sandre O; Gu F; Colin A
    Sci Rep; 2017 Jul; 7(1):4794. PubMed ID: 28684775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and processing of solid self-emulsifying drug delivery systems (HME S-SEDDS): A single-step manufacturing process via hot-melt extrusion technology through response surface methodology.
    Raman Kallakunta V; Dudhipala N; Nyavanandi D; Sarabu S; Yadav Janga K; Ajjarapu S; Bandari S; Repka MA
    Int J Pharm; 2023 Jun; 641():123055. PubMed ID: 37207857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II.
    Sarabu S; Bandari S; Kallakunta VR; Tiwari R; Patil H; Repka MA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):567-582. PubMed ID: 31046479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of PLGA microparticles with high immunoglobulin G-loaded levels and sustained-release properties obtained by spray-drying a water-in-oil emulsion.
    Arrighi A; Marquette S; Peerboom C; Denis L; Goole J; Amighi K
    Int J Pharm; 2019 Jul; 566():291-298. PubMed ID: 31150774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
    Taluja A; Bae YH
    Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.